Fosun Pharma (02196), a holding company, plans to invest 490 million yuan to establish a private equity investment fund in Suzhou Junming.

Wisdom Financial APP News, Fosun Pharma (02196) announced that on April 29, 2025, the company's holding subsidiary Suzhou Junming signed a "partnership agreement" with Henan Fukejian, Yu Jian Biological, and Zhengzhou Aviation Port Capital. All parties plan to jointly invest in establishing a target fund. The target fund will mainly invest in innovative enterprises in the medical device diagnostics, life sciences, innovative drugs, and their upstream and downstream industry chains centered in the Central Plains region.